Liver Enzymes and Their Association with Some Cardiometabolic Diseases: Evidence from a Large Kurdish Cohort
Table 5
Odds ratio (OR) and 95% CI of the MetS, HTN, and CVD with the activity of the aminotransferases in the normal range.
Variables
Prevalence (%)
Metabolic syndrome
Prevalence (%)
Hypertension
Prevalence (%)
CVD
Adjusted model OR (95% CI)
Adjusted model OR (95% CI)
Adjusted model OR (95% CI)
ALT
Quartile 1
17.7
1.00
23.2
1.00
23.9
1.00
Quartile 2
22.1
1.17 (0.96–1.42)
26.9
0.92 (0.72–1.16)
27
0.95 (0.75–1.20)
Quartile 3
27
1.68 (1.38–2.03)
27.5
0.90 (0.70–1.15)
26.8
1.02 (0.80–1.29)
Quartile 4
17.2
2.38 (1.90–2.98)
12.4
0.93 (0.69–1.26)
12.9
1.21 (0.90–1.61)
AST
Quartile 1
24.7
1.00
24.7
1.00
26.2
1.00
Quartile 2
23.6
0.95 (0.79–1.13)
24.9
0.94 (0.74–1.28)
25.4
0.97 (0.77–1.21)
Quartile 3
24.9
1.08 (0.91–1.30)
26.7
1.02 (0.81–1.29)
25.3
0.96 (0.76–1.21)
Quartile 4
19.8
1.13 (0.93–1.38)
18.7
1.02 (0.79–1.33)
17.9
1.01 (0.72–1.50)
ALT: alanine aminotransferase; AST: aspartate aminotransferase. Adjusted model for gender, age, smoking status, physical activity, and BMI. Without adjusted models.
